Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral formulation for paclitaxel

Oral formulation for paclitaxel

US Patent 6319943 · Granted Nov 20, 2001

Estimated economic value: $7,102,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manuf2022
Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manuf2019
Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manuf2015
Kit for delivering decitabine in vivo2006
Method of administering decitabine2006
Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of u2006
Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of u2006
Method for treating diseases associated with abnormal kinase activity2006
Liquid formulation of decitabine and use of the same2006
Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog2005
Methods for administration of paclitaxel2004
Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of u2004